Large Cap Archives - Page 113 of 437

1 minute read

Home Run To Homewrecker – Analyst Cautious On Homebuilders, Downgrades Key Players

January 22, 2:29 PM

Seaport analyst Kenneth Zener adjusts his stance on homebuilding stocks, downgrading key players due to a cautious outlook for FY24. With recession concerns lingering, Zener anticipates potential challenges, emphasizing the risk of anticipated tailwinds transforming into headwinds. Builder margins are expected to stabilize, influenced by diminishing past incentives, counteracted by rising input costs.

DHI

2 minute read

Rails Back On Track: Analyst Upgrades Union Pacific And Norfolk Southern, Predicts Strong Intermodal Recovery

By Lekha Gupta

January 22, 2:09 PM

Analyst David Vernon forecasts a positive trajectory for U.S. rail stocks in FY24. Navigate the evolving market with strategic upgrades: Union Pacific Corp (UNP) and Norfolk Southern Corp (NSC). UNP stands out as a top-quality investment, upgraded to Outperform, while NSC gains momentum with an Outperform rating and a compelling turnaround narrative.

CSX

2 minute read

Verizon Fourth-Quarter Earnings: Wired for Challenges Such As $5.8B Write Down, But Wireless Could Be Triumphant

By Neil Dennis

January 22, 1:49 PM

Verizon expected to post Q4 earnings per share lower than last year.

2 minute read

US Stock Market At Record Highs: Overvalued Territory Or Still A Value Buy?

By Piero Cingari

January 22, 1:34 PM

Explore the recent all-time highs of the S&P 500, Dow Jones, and Nasdaq 100. Is the US stock market now overvalued or still a bargain?

DIA

2 minute read

Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval

By Vandana Singh

January 22, 12:59 PM

FDA-approved Balversa for urothelial carcinoma treatment. The first oral FGFR kinase inhibitor offers clinical benefits, extended overall survival, and a breakthrough for FGFR alterations in metastatic UC.

AMAM

1 minute read

Why Food Processing Company Archer-Daniels-Midland Shares Are Sinking Today

By Lekha Gupta

January 22, 12:24 PM

Archer-Daniels-Midland shares nosedive 20% after placing CFO on leave amid an accounting investigation. Ismael Roig appointed as interim CFO, and the company updates FY23 outlook, projecting adjusted EPS above $6.90. Ongoing investigations prompt withdrawal of nutrition segment outlook, delaying Q4 FY23 earnings release.

ADM

2 minute read

Netflix Reports Q4 Earnings Tuesday: Several Catalysts To Watch For The Streaming Stock

By Surbhi Jain

January 22, 12:08 PM

Here's what Netflix analysts will be focusing on, and how the stock currently maps against Wall Street estimates.

NFLX

2 minute read

Procter & Gamble Q2 Earnings: Evaluating Growth Potential, Market Expectations

By Surbhi Jain

January 22, 11:11 AM

P&G reports Q2 earnings on Jan. 23, with EPS of $1.7 and revenue of $21.47B expected. Analysts see strong growth potential due to its defensive business model and focus on innovation.

1 minute read

Why Is HIV Drug Giant Gilead Stock Falling Monday?

By Vandana Singh

January 22, 10:23 AM

Gilead's Phase 3 EVOKE-01 study on Trodelvy in metastatic non-small cell lung cancer didn't meet overall survival endpoint. Despite numerical OS improvement, further exploration is planned.

GILD

3 minute read

Baby Bust: Will Falling Global Birth Rates Drive Growth And Markets Lower?

By Neil Dennis

January 22, 10:09 AM

In the U.S., the birth rate is still growing, but at a much slower rate since the global financial crisis in 2008.

AMAT